22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release here
  • Home
  • About Us
    • Our Company
    • Our Leadership Team
    • Board of Directors
  • Reduced Nicotine Tobacco
    • VLN®
    • Clinical Studies & Commentaries
  • Hemp/Cannabis Innovation
    • GVB Biopharma
  • Hops Research
  • News
  • Investors
    • Overview
    • New Investor / Latest Resources
    • Events
    • News
    • Stock Data
    • SEC Filings
    • Analyst Coverage
    • Corporate Governance
    • Annual Reports
    • FAQs
  • Contact Us

Events

Investors

Investors

  • Overview
  • New Investor / Latest Resources
  • Events
  • News
    • Press Releases
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Trades
  • SEC Filings
  • Analyst Coverage
  • Corporate Governance
  • Annual Reports
  • FAQs

22nd Century Group, Inc. First Quarter 2022 Earnings Results Webcast

May 5, 2022 10:00 am EDT
Audio
Webcast
Earnings Release
PDF
Earnings Presentation
PDF
10-Q
HTML
  • Email Alerts
  • Contact
  • RSS News Feed
© 2022 22nd Century Group, Inc. All Rights Reserved.
Privacy Policy / CCPA Disclaimer Sitemap